BridgeMD
New treatment option for Cardio Vascular Disease
Official title Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography
ClinicalTrials.gov ID: NCT07512830
What this study is testing
- What it's testing
- Transoesophageal echocardiography (TOE) is a routine cardiology examination that is performed in most cases under local anaesthesia and is recommended for many indications.The objective of our study will be to evaluate the expected beneficial effect of using conversational hypnosis and hypnosis during a transoesophageal ultrasound examination performed directly in the examination room by the cardiologist conducting the examination.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged ≥ 18 years old
- Patient requiring a transoesophageal ultrasound scan under local anaesthetic.
- Patient affiliated to a health insurance scheme
- French-speaking patient
- Patient who has given their free, informed and express verbal consent
You likely can't join if
- Patient with a contraindication to transoesophageal ultrasound (significant radiation exposure to the chest, oesophageal pathology with risk of...
- Patients with known schizophrenia or known psychiatric illness (documented in medical records)
- Patients with known dementia or known cognitive impairment (documented in medical records)
- Patients already included in an treatment research protocol
- Patients under guardianship or curatorship
- Patients deprived of their liberty
See the full eligibility criteria
- Patient aged ≥ 18 years old
- Patient requiring a transoesophageal ultrasound scan under local anaesthetic.
- Patient affiliated to a health insurance scheme
- French-speaking patient
- Patient who has given their free, informed and express verbal consent
- Patient with a contraindication to transoesophageal ultrasound (significant radiation exposure to the chest, oesophageal pathology with risk of bleeding)
- Patients with known schizophrenia or known psychiatric illness (documented in medical records)
- Patients with known dementia or known cognitive impairment (documented in medical records)
- Patients already included in an treatment research protocol
- Patients under guardianship or curatorship
- Patients deprived of their liberty
- Patients under judicial protection
- Pregnant or breastfeeding patients
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.